Figure 1 Enterohepatic actions of FXR

Nov 15, 2014

10 likes | 136 Views

Figure 1 Enterohepatic actions of FXR. Schaap, F. G. et al. (2013) Bile acid receptors as targets for drug development Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2013.151.

Share Presentation

Embed Code

Link

gastroenterol
drug development
1038 nrgastro
doi 10
figure 1 enterohepatic actions
2013 bile acid receptors

kimberly-weaver

Download Presentation

Figure 1 Enterohepatic actions of FXR

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Figure 1 Enterohepatic actions of FXR Schaap, F. G. et al.(2013) Bile acid receptors as targets for drug development Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2013.151

Figure 1

Figure 1. Figure 2. (b). (a). Figure 3. Figure 4. 1 m m. 2. 1. 3. Height. Phase. (b). (a). Figure 5. (a). (b). Figure 6. (b). (a).

144 views • 6 slides

Figure 1

Figure 1. Methanolic Homogenate / Three-Phase Separation. Lower Phase Upper Phase Interface/ Interface/. CMW Insoluble. CMW Soluble. DEAE-cellulose. AG1-X2. DEAE-cellulose (optional). nuc-sugars bisphosphates. free glycans.

157 views • 3 slides

Figure 1

LFA classes, go here. Figure 1. Find the month and class, then based on class size, see if there are openings. If the class is full, you can register (and place) the person on a wait list. This is a good option, you just have to check it regularly.

246 views • 3 slides

Figure 1

a. d. b. e. c. f. Effect of different induction strength of one chaperone team at constant induction strength of the other chaperone. Figure 1. 80 66 47 40 35 29 17. 1 2 3 4. STD Streptokinase. Degraded Fragments ~35 kDa.

237 views • 6 slides

Figure 1

Figure 1. Eligible GPs. Eligible GPs. Questionnaire. Questionnaire. on. on. Participation. Participation. No 902. No 902. 1194. 1194. screening. screening. attitudes. attitudes. in trial. in trial. 292. 292. 700. 700. Sampling. Sampling. 130. 130. Sampling. Sampling.

86 views • 1 slides

Figure 1

Class. Figure 1. Order. Figure 3. Order. Table 6 – Archaea representatives and their respective importance in each library. Figure 6. Figure 2. Figure 4. Carbon cycle. ↑ CO 2. Figure 5. ↓ Denitrifiers Streptomyces Bacillus. ↑ Respiration.

303 views • 1 slides

Figure 1.

Figure 1. a. c. b. d. Figure 2. a. e. b. f. c. g. d. h. Figure 3. B. Figure 4. Figure 5.

163 views • 5 slides

Figure 1

LiuPan mountains. Figure 1. Figure 2. 20. 15. 10. Species. S obs. 5. Michaelis-Menten. Chao1. Jackknife2. 0. 0. 20. 40. 60. 80. 100. Samples. Figure 3. Afforestation gradient. Deforestation gradient. Afforested set-aside fields. Woody shrub. Non-woody shrub.

163 views • 7 slides

Figure 1

150. 100. 50. 0. 1000. 800. 600. 400. 150. 200. 0. 100. 50. 0. Figure 1. A. FABP4 mRNA levels relative to WT SC controls. *. *. WT. shFABP4. WT. shFABP4. HFD. SC. B. FABP5 mRNA levels relative to WT SC controls. WT. shFABP4. WT. shFABP4. HFD. SC. C.

207 views • 6 slides

Figure 1.

Figure 1. Figure 2. Figure 3. a2 [umoleCO2/m2/s/degC]. a 1 [umoleCO2/m2/s]. a 3 [umoleCO2/m2/s]. -a 3 /a 4 [umoleCO2/m2/s/umole-photon]. Figure 4. Model-0 parameter a 1 vs. mean T air. Early summer. 5. late spring. Mid-summer. 4. late summer. early spring.

701 views • 59 slides

Figure 1

Figure 1. Caseflow Management. Information Technology Management. Leadership. Purposes and Responsibilities of Courts. Education, Training and Development. Visioning and Strategic Planning. Human Resource Management. Essential Components. Court Community Communication.

108 views • 1 slides

Figure 1

A. Wound closure. B. Cell death area. C. LDH release. (mm 2 per 24 h). (mm 2 ). (LDH assay, O.D.). 1. 0.5. 0.3. ***. ***. ***. 0.4. 0.75. 0.2. 0.3. 0.5. 0.2. 0.1. 0.25. 0.1. 0. 0. 0. D. Cell viability. E. Cell proliferation. (MTT test, O.D.).

210 views • 7 slides

Figure 4 Potential targets of FXR and TGR5 agonists in NASH

Figure 4 Potential targets of FXR and TGR5 agonists in NASH. Schaap, F. G. et al. (2013) Bile acid receptors as targets for drug development Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2013.151.

1.05k views • 1 slides

Figure 1 Anti-inflammatory actions of statins in rheumatoid arthritis

Figure 1 Anti-inflammatory actions of statins in rheumatoid arthritis. Bisoendial, R. J. et al. (2010) Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2009.277.

194 views • 1 slides

Figure 1.

A. B. Figure 1. Marker. Rat. Rat. BRL cell. Marker. BRL cell. B. A. 586bp. 471bp. Figure 2. Marker. BRL cell. Rat. Marker. M. D. U. C. 601bp. 201bp. Figure 2. 208bp. Marker. E. 480bp. 381bp. 330bp. 457bp. Figure 2. A. Figure 3. B. Figure 3. 120.

208 views • 7 slides

Figure 1

Figure 1.

77 views • 1 slides

Figure 4 Proposed actions of metformin in cancer

Figure 4 Proposed actions of metformin in cancer. Pernicova, I. & Korbonits, M. (2014) Metformin—mode of action and clinical implications for diabetes and cancer Nat. Rev. Endocrinol. doi:10.1038/nrendo.2013.256.

309 views • 1 slides

Figure 1

B. PMN depletion. Control. A. PMN and macrophage depletion. PMN depletion. 100. 100. 75. 75. SURVIVAL (%). SURVIVAL (%). 50. 50. 25. 25. 0. 0. 0. 1. 2. 3. 4. 5. 0. 1. 2. 3. 4. 5. TIME (days). TIME (days). 1 x 10 6 A. fumigatus /mouse. 1 x 10 7 A. fumigatus /mouse.

83 views • 1 slides

FIGURE 1

52 kDa. FIGURE 1. A. B. TOTAL. SUPERFICIE. Met1&4 (0.1). Met1&4 (0.1). Met4 (0.1). Met4 (0.1). i). control. control. i). 101 kDa. 52 kDa. BC. ii). ii). 52 kDa. 52 kDa. iii). BC.

86 views • 2 slides

FIGURE 1

FIGURE. 536 E. Michigan Ave., Suite 300, Kalamazoo, MI 49007 phone (269) 344-7117 fax (269) 344-2493. Lake Outflow. Site #1 north of 4484 E. Cedar Lake Dr.

85 views • 1 slides

Figure 1

Figure 1. HCT116-s. HCT116-SN6. -S. -A2. -SN50. -C8. -G7. NT. SN38. NT. SN38. [SN38] 24H. SN38 1µM. NT 0.1µM 1µM 5µM 10µM. NT 1h 4h 7h 16h 24h 48h. A. pp38. pp38. HCT116-s. HCT116-s. tubulin. tubulin. pp38. pp38. HCT116-SN6. HCT116-SN6.

104 views • 9 slides

More Related